Why is Godavari Drugs falling/rising?

As of 28-Jul, Godavari Drugs Ltd is experiencing a decline in its stock price, currently at Rs 84.50, reflecting a decrease of Rs 3.03 or 3.46%. The stock has underperformed its sector by 3.54% today and opened with a loss of 2.55%. It reached an intraday low of Rs 83, marking a drop of 5.18%. Over the past week, the stock has fallen by 4.57%, and year-to-date, it has seen a significant decline of 22.73%. The company's recent performance is concerning, with a notable decrease in delivery volume by 76.47% against the five-day average, and it is trading below all key moving averages. Additionally, while the stock has a relatively attractive valuation with a ROCE of 12.3, its profits have decreased by 22.1% over the past year, contributing to the negative sentiment surrounding the stock. In the broader market context, Godavari Drugs has underperformed compared to the Sensex, which has gained 3.52% year-to-date, while Godavari has lost 22.73%. The stock's long-term fundamentals are weak, evidenced by a high Debt to EBITDA ratio of 3.15 times and a significant drop in PAT and net sales over the latest six months. This underperformance is compounded by the company's inability to service its debt and a lack of investor participation, further driving down the stock price. Overall, the combination of poor financial results, declining investor interest, and a challenging market environment has led to the stock's current downward trajectory.